The African-European Tuberculosis Consortium (AE-TBC) is an international multisite group of African and European researchers who investigate the use of host biosignatures for the diagnosis of active TB disease. For over ten years, the LUMC groups of Infectious Diseases and Cell & Chemical Biology from Prof Annemieke Geluk and Dr Paul Corstjens respectively, have been partners of the EDCTP consortia for tuberculosis (among which AE-TBC). The AE-TBC recently won the prize for ‘Outstanding Research Team 2020, awarded by the EDCTP.
This prize is awarded to outstanding research teams in sub-Saharan Africa and Europe working on HIV/AIDS, tuberculosis, malaria and neglected infectious diseases (NID) in the scope of the EDCTP2 programme.
Professor Gerhard Walzl of AE-TBC upon accepting the EDCTP Outstanding Research Team prize: “I think the success of the AE-TBC shows that African institutions can lead international research effectively”
Edouard Fu, PhD student at the Department of Clinical Epidemiology at the LUMC, uses big data to study the effectiveness and safety of kidney, diabetes and heart failure treatments. With a Rubicon grant from NWO, Edouard will conduct further research at Harvard Medical School over the next two years.
On June 23rd, we organized the first LUMC Global Community Meeting on establishing successful Sino-Dutch collaborations in (bio)medical research and education.
Together with the TU Delft | Global Initiative, LUMC Global has set up a collaborative research workshop which kicks off today. Students enrolled in the workshop will partake in a study to primarily analyze the correlation between spatial conditions of residential neighbourhoods and buildings, and health. They will develop a comparative analysis of two neighbourhoods in The Hague.